205 Preliminary characterization of ovarian stem cells from bovine ovaries

2020 ◽  
Vol 32 (2) ◽  
pp. 231
Author(s):  
A. Denicol ◽  
B. Weldon ◽  
L. Aguiar

Ovarian stem cells (OSCs) have been reportedly isolated from ovaries of rodents, pigs, humans, and cattle by targeting the germ cell marker protein DDX4. Although the role of OSCs in female reproduction is unknown, the ability to culture OSCs and differentiate oocytes invitro could benefit the cattle industry and the study of oogenesis. The aim of this study was to describe isolation and preliminary characterisation of putative bovine OSCs. Slaughterhouse-derived ovaries from adult cows were processed by mechanical and enzymatic dissociation into a single cell suspension followed by immunostaining. Cells were incubated in blocking solution followed by 10µgmL−1 rabbit anti-human polyclonal DDX4 antibody (#13840; Abcam) for 15min and 2µgmL−1 goat anti-rabbit IgG labelled with Alexa Fluor 647 for 15min in the dark. Next, cells were resuspended in Hanks’ balanced salt solution with 1% bovine serum albumin/25mM HEPES, filtered through a 30-µm strainer and subjected to fluorescence-activated cell sorting. Controls used to establish gates were unstained cells and cells incubated with secondary antibody only. 4’,6-Diamidino-2-phenylindole (DAPI) exclusion was used as a viability test. Putative OSCs were placed in culture in OSC medium (MEMα Glutamax containing 10% fetal bovine serum, 1mM sodium pyruvate, 1× nonessential amino acids, 103 units of leukemia inhibitory factor, 10µgmL−1 glial cell-derived neurotrophic factor, 10µgmL−1 basic fibroblast growth factor, 1µgmL−1 epidermal growth factor, 1× N2-max, penicillin/streptomycin) for expansion and characterisation by gene expression using reverse transcription-PCR and protein expression using immunolocalization and confocal microscopy. To ensure specificity against bovine DDX4, the same antibody used for cell sorting was used to label oocytes within ovarian follicles in histological sections. Two cell lines were obtained and expanded invitro. Gene expression was performed in putative OSCs at passages 1 to 3; cumulus-oocyte complexes (COCs) were used as positive controls and adult skin fibroblasts as negative controls, and ACTB was used as an endogenous control. Both putative OSC lines and COCs expressed the germ cell markers DAZL and C-KIT, and COCs also expressed BMP15. Only ACTB was detected in fibroblasts. Immunolocalization was performed in putative OSCs at passage 4, with oocytes and fibroblasts used as positive and negative controls. Additional controls were cells exposed to secondary antibody only. Both putative OSC lines and oocytes expressed DAZL and DDX4 and no marker was detected in fibroblasts. Next, OSC line #2 was transfected with a retroviral vector using the EF1α promoter for green fluorescent protein (GFP) expression. This is a critical step to ensure the success of experiments requiring cell tracking. Transfected cells were expanded and sorted to establish a pure population of GFP+ OSCs. To verify replication deficiency of the viral particles, supernatant from GFP+ OSCs was collected 1 passage after transfection and applied to GFP- OSCs. No GFP+ cells were observed after 24, 48, or 72h. These preliminary results confirm the presence of putative OSCs in the ovaries of cows of reproductive age. If these cells are capable of invitro differentiation, they could provide a powerful tool to study oogenesis and further develop assisted reproductive technologies.

Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 4997-4997
Author(s):  
Lu Zhang ◽  
Susanne Hofmann ◽  
Lars Bullinger ◽  
Marlies Goetz ◽  
Markus Wiesneth ◽  
...  

Abstract Abstract 4997 Leukemic stem cells (LSC) are the source for leukemic disease self-renewal and account for disease relapse after treatment. Therefore LSCs probably represent a critical target for therapeutic options. Xenograft models confirmed repeatedly that LSCs from AML patients reside mainly in CD34+CD38- compartment of leukemic blasts which makes the pure and efficient separation of this population mandatory to identify new therapeutic drugs to target LSC in different AML subtypes. We separated this subpopulation out of primary AML peripheral blood mononuclear cells (PBMC) samples with fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) and compared the efficiency of both methods. In order to profile gene expression of LSCs and hematopoietic stem cells (HSC) MicroArrays were performed using GeneChip Human Genome U133 Plus 2.0 from Affymetrix. The CD34+CD38- subpopulation was separated from PBMCs of 12 AML patients and 5 healthy volunteers using FACS. Concerning the 12 primary AML samples, the ratio of CD34+CD38- cells ranges between 0.79% and 86.2% using 1–5×107 PBMC for separation. After sorting, the purity of those AML samples increased to 88.4–98.4% while 2×104-3.6×106 cells were obtained. MACS was used to separate 2 representative samples, in which the CD34+CD38- subpopulation was rather small (sample1: 0.78%) or large (sample2: 86.1%). Those sorted subpopulations were compared to the samples sorted via FACS. In order to evaluate separation efficiency in a standardized manner, we defined the recovery rate: (CD34+CD38- cell number obtained /total CD34+CD38- cell number) × 100%. The total CD34+CD38- cell number was calculated through a pre-sorting FACS analysis. For sample 1, MACS resulted in a recovery rate of 4.2–6.4% with a purity of 86.6–90.3%, which is inferior to the recovery rate of 17% and the purity of 92.1% using FACS. For Sample 2, MACS resulted in a recovery rate of 0.4% with a purity of 98.8%, compared to the recovery rate of 11.6% with a purity of 98.1% by FACS. Comparing both methods it is obvious that the purity doesn't differ a lot, but the yield is much higher using FACS. This could represent a powerful tool, when managing rare samples. Finally, by comparing purity and yield, we showed that FACS is the adequate separation method. At the moment MicroArrays are being performed in order to investigate the gene expression profile for 12–15 AML patients and 5 HVs. Taken together, we showed a widely efficient method to routinely separate LSCs from patients with different subtypes of AML. Microarrays, that have been performed, represent a method that allows the comparison of the characteristics of LSCs in different AML subtypes and also of LSCs from bone-marrow with LSCs from peripheral blood and with HVs. These array data analyses are ongoing and will be presented. Disclosures: No relevant conflicts of interest to declare.


2012 ◽  
Vol 150 (1-3) ◽  
pp. 137-146 ◽  
Author(s):  
Mohammad Ghasemzadeh-Hasankolai ◽  
Roozali Batavani ◽  
Mohamadreza Baghaban Eslaminejad ◽  
Mohammadali Sedighi-Gilani

Author(s):  
Bing Zhang ◽  
Megan He ◽  
Ya-Chieh Hsu

Abstract Melanocyte stem cells (MeSCs) are crucial for generating mature melanocytes that colour the skin and hair. Dysfunction of MeSCs can result in conditions such as hair greying, hypo- or hyper-pigmentation disorders, and melanoma. Here we describe a fluorescence-activated cell sorting (FACS) strategy for isolating MeSCs from mouse skin. The isolated MeSCs can be used in a multitude of experiments including gene expression analysis, transplantation, and others.


F1000Research ◽  
2020 ◽  
Vol 7 ◽  
pp. 622
Author(s):  
Ahmed Othman ◽  
Rabab Mubarak ◽  
Dina Sabry

Background: Stem cells from human exfoliated deciduous teeth (SHEDs) are considered one of the most convenient sources of adult stem cells. This study aimed to examine the effect of fibroblast growth factor 6 (FGF-6) on SHEDs and evaluate CDK2 and MATK gene expression in SHED-derived microvesicles (MVs). SHEDs were cultured from deciduous teeth pulp. Methods: SHEDs were divided into two groups: the control group and test groups, with and without FGF-6 supplementation, respectively. After the third passage, SHED proliferation was assessed by MTT assay. MVs were purified and CDK2 and MATK gene expression was assessed by real-time polymerase chain reaction. SHEDs were identified by their positivity for CD90 and CD73, and negativity for CD45 and CD34. Results: SHEDs proliferation in the test group was significantly higher than in the control group (P<0.001). mRNA from SHED-derived MVs from the test group exhibited a markedly elevated expression of CDK2 and MATK, (P<0.002 and P<0.005, respectively) in comparison with those of the control group. FGF-6 enhanced the proliferation of SHEDs. Proliferation enhancement is favorable for the production of a large number of stem cells, which will then be beneficial for cell-based therapies. Conclusions: CDK2 and MATK genes in SHED-derived MVs can be used as molecular biomarkers for SHED proliferation.


Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 1785-1785
Author(s):  
Patrick C Chang ◽  
Janine M Low-Marchelli ◽  
Ashkan Shahbandi ◽  
Daniel J Goff ◽  
Catriona Jamieson

Abstract Chronic Myeloid Leukemia (CML) is a progressive hematopoietic malignancy where expression of the oncogenic fusion protein BCR-ABL1 in leukemia stem cells (LSCs) prevents the proper differentiation of myeloid progenitor populations, leading to accumulation of undifferentiated blasts. Current treatments target BCR-ABL1 with tyrosine kinase inhibitors (TKIs). Though effective if administered continuously, TKIs generally fail to eradicate the bone marrow niche-residing LSCs responsible for patient relapse or progression of CML to its terminal stage, Blast Crisis (BC), as evidenced by the high molecular relapse rate following TKI discontinuation. Previous studies performed by ourselves and others show that BC progenitors (CD34+CD38+Lin-) exhibit stem-like behaviors, such as quiescence, self-renewal, and induction of pro-survival gene expression through alternative splicing of BCL2 family members, and thus behave like LSCs. Notably, BC CML LSCs co-cultured on LSC (SL/M2) supportive stroma are resistant to TKIs compared to culturing the cells alone, indicating a role of the extracellular matrix (ECM) in promoting LSC survival. We performed RNA-seq and qRT-PCR of CD34+CD38+Lin- progenitor cells in CML patient samples and found a significant increase in CTGF (Connective Tissue Growth Factor) expression in BC CML versus chronic phase (CP). Interestingly, CTGF is an ECM protein that enhances cell adhesion and has been shown to predict therapeutic resistance in cancers, such as acute lymphoblastic leukemia (ALL). Lentiviral overexpression of CTGF in a CML cell line K562 and CD34+ CP CML patient samples caused proliferation and a decrease in apoptosis markers (cleaved caspase-3), as measured by FACS analysis. Moreover, qRT-PCR analysis of mRNA indicated an increase in pro-survival BCL2 family gene expression. These changes were not observed in normal CD34+ cord blood cells. Currently, lentiviral CTGF transduction of CP CML followed by transplantation into RAG2-/-gc-/- and NSG-S mice will be used to determine the effects of CTGF on LSC maintenance in vivo. In conclusion, CTGF promotes CML LSC survival in vitro and thus could be a key factor in BC transformation and TKI resistance. Disclosures Jamieson: J&J, Roche: Research Funding.


Sign in / Sign up

Export Citation Format

Share Document